Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net (loss) income $ (39,719,147) $ 2,778,873
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Share-based compensation expense 857,628 825,808
Loss on issuance of common shares, warrants, and pre-funded warrants in July 26, 2024 PIPE   3,524,535
Change in fair value of financial instruments (5,592) (22,581,477)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 2,555,126 (4,598,597)
Accounts payable 805,952 (6,105,673)
Accrued liabilities 7,387,454 (1,025,564)
Net cash used in operating activities (28,118,579) (27,182,095)
Cash flows from investing activities    
Purchase of short-term investments (33,753) (33,051)
Maturity of short-term investment 33,051 32,358
Net cash used in investing activities (702) (693)
Cash flows from financing activities    
Proceeds from issuance of Common Shares pursuant to 2025 and 2024 ATM offering, respectively, net of issuance costs 708,468 190,274
Proceeds from exercise of pre-funded warrants 3,050 28,038
Net cash provided by financing activities 20,944,670 27,875,809
Net (decrease) increase in cash (7,174,611) 693,021
Cash at beginning of period 13,291,167 12,598,146
Cash at end of period 6,116,556 13,291,167
Noncash financing activities    
Reclassification of July 2024 PIPE warrants from liability to equity   8,689,148
Decrease in share-based compensation liability on CAD denominated share options increasing additional paid-in-capital (170,081) 222,739
Supplemental disclosure of cash flow information    
Cash paid for interest   76,775
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering    
Cash flows from financing activities    
Proceeds from issuance of pre-funded warrants from July 22, 2025 Registered Direct Offering, net of issuance costs 697,658  
Proceeds from issuance of common shares, pre-funded warrants and accompanying common warrants from Private Placements, net of issuance costs 8,391,027  
Noncash financing activities    
Deferred discount for fair value modification of warrants 930,841  
Deferred discount issuance cost recognized on completion of PIPE (930,841)  
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering    
Cash flows from financing activities    
Proceeds from issuance of common shares, pre-funded warrants and accompanying common warrants from Private Placements, net of issuance costs 11,144,467  
Noncash financing activities    
Deferred discount for fair value modification of warrants 1,794,146  
Deferred discount issuance cost recognized on completion of PIPE $ (1,794,146)  
July 2024 Pipe Financing    
Cash flows from financing activities    
Proceeds from issuance of common shares, pre-funded warrants and accompanying common warrants from Private Placements, net of issuance costs   $ 27,657,497